121
Views
85
CrossRef citations to date
0
Altmetric
Article

Pten Null Prostate Epithelium Promotes Localized Myeloid-Derived Suppressor Cell Expansion and Immune Suppression during Tumor Initiation and Progression

, , , , , , , , , & show all
Pages 2017-2028 | Received 17 Jan 2014, Accepted 14 Mar 2014, Published online: 20 Mar 2023

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (6)

Julia Koerner, Dennis Horvath, Franziska Oliveri, Jun Li & Michael Basler. (2023) Suppression of prostate cancer and amelioration of the immunosuppressive tumor microenvironment through selective immunoproteasome inhibition. OncoImmunology 12:1.
Read now
Chen Chen, Yanlong Liu & Binbin Cui. (2021) Effect of radiotherapy on T cell and PD-1 / PD-L1 blocking therapy in tumor microenvironment. Human Vaccines & Immunotherapeutics 17:6, pages 1555-1567.
Read now
Yuan Zhuang, Chang Liu, Jiaqing Liu & Guang Li. (2020) Resistance Mechanism of PD-1/PD-L1 Blockade in the Cancer-Immunity Cycle. OncoTargets and Therapy 13, pages 83-94.
Read now
Ryuji Yamaguchi & Guy Perkins. (2018) Animal models for studying tumor microenvironment (TME) and resistance to lymphocytic infiltration. Cancer Biology & Therapy 19:9, pages 745-754.
Read now
Aitziber Buqué, Norma Bloy, Fernando Aranda, Isabelle Cremer, Alexander Eggermont, Wolf Hervé Fridman, Jitka Fucikova, Jérôme Galon, Radek Spisek, Eric Tartour, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2016) Trial Watch—Small molecules targeting the immunological tumor microenvironment for cancer therapy. OncoImmunology 5:6.
Read now
Baijun Dong, Laurie J Minze, Wei Xue & Wenhao Chen. (2014) Molecular insights into the development of T cell-based immunotherapy for prostate cancer. Expert Review of Clinical Immunology 10:11, pages 1547-1557.
Read now

Articles from other publishers (79)

Sofia Bruni, María Florencia Mercogliano, Florencia Luciana Mauro, Rosalia Inés Cordo Russo & Roxana Schillaci. (2023) Cancer immune exclusion: breaking the barricade for a successful immunotherapy. Frontiers in Oncology 13.
Crossref
Kiranj Chaudagar, Hanna M. Hieromnimon, Rimpi Khurana, Brian Labadie, Taghreed Hirz, Shenglin Mei, Raisa Hasan, Jordan Shafran, Anne Kelley, Eva Apostolov, Ghamdan Al-Eryani, Kate Harvey, Srikrishnan Rameshbabu, Mayme Loyd, Kaela Bynoe, Catherine Drovetsky, Ani Solanki, Erica Markiewicz, Marta Zamora, Xiaobing Fan, Stephan Schürer, Alex Swarbrick, David B. Sykes & Akash Patnaik. (2023) Reversal of Lactate and PD-1–mediated Macrophage Immunosuppression Controls Growth of PTEN/p53-deficient Prostate Cancer. Clinical Cancer Research 29:10, pages 1952-1968.
Crossref
Antoinette van Weverwijk & Karin E. de Visser. (2023) Mechanisms driving the immunoregulatory function of cancer cells. Nature Reviews Cancer 23:4, pages 193-215.
Crossref
Chi Yin, Min Wang, Yingzhao Wang, Qijun Lin, Kaiyuan Lin, Hong Du, Chuandong Lang, Yuhu Dai & Xinsheng Peng. (2023) BHLHE22 drives the immunosuppressive bone tumor microenvironment and associated bone metastasis in prostate cancer. Journal for ImmunoTherapy of Cancer 11:3, pages e005532.
Crossref
Giuseppe Bronte, Vincenza Conteduca, Matteo Landriscina & Antonio Domenico Procopio. (2022) Circulating myeloid-derived suppressor cells and survival in prostate cancer patients: systematic review and meta-analysis. Prostate Cancer and Prostatic Diseases 26:1, pages 41-46.
Crossref
Yuting Zhang, Sean Murphy & Xin Lu. 2023. Myeloid-derived suppressor cells. Myeloid-derived suppressor cells 1 31 .
Liqian Niu, Eungyo Jang, Ai Lin. Chin & Rong Tong. 2023. Encyclopedia of Nanomaterials. Encyclopedia of Nanomaterials 673 717 .
José Basílio, Bernhard Hochreiter, Bastian Hoesel, Emira Sheshori, Marion Mussbacher, Rudolf Hanel & Johannes A. Schmid. (2022) Antagonistic Functions of Androgen Receptor and NF-κB in Prostate Cancer—Experimental and Computational Analyses. Cancers 14:24, pages 6164.
Crossref
Alexandre A Germanos, Sonali Arora, Ye Zheng, Erica T Goddard, Ilsa M Coleman, Anson T Ku, Scott Wilkinson, Hanbing Song, Nicholas J Brady, Robert A Amezquita, Michael Zager, Annalysa Long, Yu Chi Yang, Jason H Bielas, Raphael Gottardo, David S Rickman, Franklin W Huang, Cyrus M Ghajar, Peter S Nelson, Adam G Sowalsky, Manu Setty & Andrew C Hsieh. (2022) Defining cellular population dynamics at single-cell resolution during prostate cancer progression. eLife 11.
Crossref
Jessica A. Lapierre, Lauren A. Geary, Julie K. Jang, Alan L. Epstein, Frank Hong & Jean C. Shih. (2022) Deletion of monoamine oxidase A in a prostate cancer model enhances anti-tumor immunity through reduced immune suppression. Biochemical and Biophysical Research Communications 634, pages 100-107.
Crossref
Janielle P. Maynard, Taylor N. Godwin, Jiayun Lu, Igor Vidal, Tamara L. Lotan, Angelo M. De Marzo, Corinne E. Joshu & Karen S. Sfanos. (2022) Localization of macrophage subtypes and neutrophils in the prostate tumor microenvironment and their association with prostate cancer racial disparities. The Prostate 82:16, pages 1505-1519.
Crossref
Loretah Chibaya, Jarin Snyder & Marcus Ruscetti. (2022) Senescence and the tumor-immune landscape: Implications for cancer immunotherapy. Seminars in Cancer Biology 86, pages 827-845.
Crossref
Helen M. Wise, Adam Harris, Nisha Kriplani, Adam Schofield, Helen Caldwell, Mark J. Arends, Ian M. Overton & Nick R. Leslie. (2022) PTEN Protein Phosphatase Activity Is Not Required for Tumour Suppression in the Mouse Prostate. Biomolecules 12:10, pages 1511.
Crossref
Chengzhi Gao, Guangming Zhou, Min Cheng, Lan Feng, Pengbo Cao & Gangqiao Zhou. (2022) Identification of senescence-associated long non-coding RNAs to predict prognosis and immune microenvironment in patients with hepatocellular carcinoma. Frontiers in Genetics 13.
Crossref
Chiel van Geffen, Constantin Heiss, Astrid Deißler & Saeed Kolahian. (2022) Pharmacological modulation of myeloid-derived suppressor cells to dampen inflammation. Frontiers in Immunology 13.
Crossref
Decao Niu, Yifeng Chen, Hua Mi, Zengnan Mo & Guijian Pang. (2022) The epiphany derived from T-cell–inflamed profiles: Pan-cancer characterization of CD8A as a biomarker spanning clinical relevance, cancer prognosis, immunosuppressive environment, and treatment responses. Frontiers in Genetics 13.
Crossref
Peiwen Chen & Prasenjit Dey. (2022) Co-dependencies in the tumor immune microenvironment. Oncogene 41:31, pages 3821-3829.
Crossref
Pengfei Xu, Logan J. Wasielewski, Joy C. Yang, Demin Cai, Christopher P. Evans, William J. Murphy & Chengfei Liu. (2022) The Immunotherapy and Immunosuppressive Signaling in Therapy-Resistant Prostate Cancer. Biomedicines 10:8, pages 1778.
Crossref
Izabela Siemińska & Jarek Baran. (2022) Myeloid-Derived Suppressor Cells as Key Players and Promising Therapy Targets in Prostate Cancer. Frontiers in Oncology 12.
Crossref
Talha Bin Emran, Asif Shahriar, Aar Rafi Mahmud, Tanjilur Rahman, Mehedy Hasan Abir, Mohd. Faijanur - Rob Siddiquee, Hossain Ahmed, Nova Rahman, Firzan Nainu, Elly Wahyudin, Saikat Mitra, Kuldeep Dhama, Mahmoud M. Habiballah, Shafiul Haque, Ariful Islam & Mohammad Mahmudul Hassan. (2022) Multidrug Resistance in Cancer: Understanding Molecular Mechanisms, Immunoprevention and Therapeutic Approaches. Frontiers in Oncology 12.
Crossref
Barbara Seliger & Chiara Massa. (2022) Modulation of Lymphocyte Functions in the Microenvironment by Tumor Oncogenic Pathways. Frontiers in Immunology 13.
Crossref
Adam A. Kraya, Kara N. Maxwell, Monika A. Eiva, Bradley Wubbenhorst, John Pluta, Michael Feldman, Anupma Nayak, Daniel J. PowellJrJr, Susan M. Domchek, Robert H. Vonderheide & Katherine L. Nathanson. (2022) PTEN Loss and BRCA1 Promoter Hypermethylation Negatively Predict for Immunogenicity in BRCA-Deficient Ovarian Cancer . JCO Precision Oncology:6.
Crossref
Yangyi Zhang, Bethany K. Campbell, Stanley S. Stylli, Niall M. Corcoran & Christopher M. Hovens. (2022) The Prostate Cancer Immune Microenvironment, Biomarkers and Therapeutic Intervention. Uro 2:2, pages 74-92.
Crossref
Priyanka Singh, Monika Yadav, Karishma Niveria & Anita Kamra Verma. (2022) Nano-immunotherapeutics: targeting approach as strategic regulation at tumor microenvironment for cancer treatment. Exploration of Medicine, pages 22-42.
Crossref
Zhi Qi, Zihan Xu, Liuzhen Zhang, Yongkang Zou, Jinping Li, Wenyu Yan, Cheng Li, Ningshu Liu & Hong Wu. (2022) Overcoming resistance to immune checkpoint therapy in PTEN-null prostate cancer by intermittent anti-PI3Kα/β/δ treatment. Nature Communications 13:1.
Crossref
L. P. Chaves, C. M. Melo, W. Lautert-Dutra, A. L. Caliari & J. A. Squire. 2022. Transcriptomics in Health and Disease. Transcriptomics in Health and Disease 299 315 .
Sangyub Kim, Li Li, Jinhui Zhang, Cheng Jiang & Junxuan Lü. (2021) Aqueous metabolome of tissue‐specific conditional Pten ‐knockout mouse prostate cancer and TRAMP neuroendocrine carcinoma . The Prostate 82:1, pages 154-166.
Crossref
Filippos Koinis, Anastasia Xagara, Evangelia Chantzara, Vassiliki Leontopoulou, Chrissovalantis Aidarinis & Athanasios Kotsakis. (2021) Myeloid-Derived Suppressor Cells in Prostate Cancer: Present Knowledge and Future Perspectives. Cells 11:1, pages 20.
Crossref
Wenchang Yue, Xiao Du, Xuhong Wang, Niu Gui, Weijie Zhang, Jiale Sun, Jiawei You, Dong He, Xinyu Geng, Yuhua Huang & Jianquan Hou. (2021) Prognostic values of the core components of the mammalian circadian clock in prostate cancer. PeerJ 9, pages e12539.
Crossref
Belinda L. Sun. (2021) Immunotherapy in treatment of metastatic prostate cancer: An approach to circumvent immunosuppressive tumor microenvironment. The Prostate 81:15, pages 1125-1134.
Crossref
Danique E.M. Duits & Karin E. de Visser. (2021) Impact of cancer cell-intrinsic features on neutrophil behavior. Seminars in Immunology 57, pages 101546.
Crossref
Camila Morais Melo, Thiago Vidotto, Luiz Paulo Chaves, William Lautert-Dutra, Rodolfo Borges dos Reis & Jeremy Andrew Squire. (2021) The Role of Somatic Mutations on the Immune Response of the Tumor Microenvironment in Prostate Cancer. International Journal of Molecular Sciences 22:17, pages 9550.
Crossref
Tao Wang, Brian Lewis, Ameer Elaimy, Marcus Ruscetti, Mitchell Sokoloff, Kriti Mittal & Thomas J. FitzGerald. 2021. Prostate Cancer. Prostate Cancer 97 112 .
Yibing Chen, Huan Jin, Yucen Song, Ting Huang, Jun Cao, Qing Tang & Zhengzhi Zou. (2020) Targeting tumor‐associated macrophages: A potential treatment for solid tumors. Journal of Cellular Physiology 236:5, pages 3445-3465.
Crossref
Dhruv Bansal, Melissa A. Reimers, Eric M. Knoche & Russell K. Pachynski. (2021) Immunotherapy and Immunotherapy Combinations in Metastatic Castration-Resistant Prostate Cancer. Cancers 13:2, pages 334.
Crossref
Violena Pietrobon & Francesco M. Marincola. (2021) Hypoxia and the phenomenon of immune exclusion. Journal of Translational Medicine 19:1.
Crossref
Giacomo Canesin. 2021. The Cancer Stem Cell Niche. The Cancer Stem Cell Niche 137 175 .
Vildan B. Cetintas & Nizar N. Batada. (2020) Is there a causal link between PTEN deficient tumors and immunosuppressive tumor microenvironment?. Journal of Translational Medicine 18:1.
Crossref
Adriana Torres Crigna, Marek Samec, Lenka Koklesova, Alena Liskova, Frank A. Giordano, Peter Kubatka & Olga Golubnitschaja. (2020) Cell-free nucleic acid patterns in disease prediction and monitoring—hype or hope?. EPMA Journal 11:4, pages 603-627.
Crossref
Sujit S. Nair, Rachel Weil, Zachary Dovey, Avery Davis & Ashutosh K. Tewari. (2020) The Tumor Microenvironment and Immunotherapy in Prostate and Bladder Cancer. Urologic Clinics of North America 47:4, pages e17-e54.
Crossref
Daniel J. Turnham, Nicholas Bullock, Manisha S. Dass, John N. Staffurth & Helen B. Pearson. (2020) The PTEN Conundrum: How to Target PTEN-Deficient Prostate Cancer. Cells 9:11, pages 2342.
Crossref
Charles M. Haughey, Debayan Mukherjee, Rebecca E. Steele, Amy Popple, Lara Dura-Perez, Adam Pickard, Mehjabin Patel, Suneil Jain, Paul B. Mullan, Rich Williams, Pedro Oliveira, Niamh E. Buckley, Jamie Honeychurch, Simon S. McDade, Timothy Illidge, Ian G. Mills & Sharon L. Eddie. (2020) Investigating Radiotherapy Response in a Novel Syngeneic Model of Prostate Cancer. Cancers 12:10, pages 2804.
Crossref
Koji Hatano, Kazutoshi Fujita & Norio Nonomura. (2020) Application of Anti-Inflammatory Agents in Prostate Cancer. Journal of Clinical Medicine 9:8, pages 2680.
Crossref
Johann S. de Bono, Christina Guo, Bora Gurel, Angelo M. De Marzo, Karen S. Sfanos, Ram S. Mani, Jesús Gil, Charles G. Drake & Andrea Alimonti. (2020) Prostate carcinogenesis: inflammatory storms. Nature Reviews Cancer 20:8, pages 455-469.
Crossref
Umayal Sivagnanalingam, Pamela L. Beatty & Olivera J. Finn. (2020) Myeloid derived suppressor cells in cancer, premalignancy and inflammation: A roadmap to cancer immunoprevention. Molecular Carcinogenesis 59:7, pages 852-861.
Crossref
Thiago Vidotto, Camila Morais Melo, Erick Castelli, Madhuri Koti, Rodolfo Borges dos Reis & Jeremy A. Squire. (2020) Emerging role of PTEN loss in evasion of the immune response to tumours. British Journal of Cancer 122:12, pages 1732-1743.
Crossref
Roberta Coletti, Lorena Leonardelli, Silvia Parolo & Luca Marchetti. (2020) A QSP model of prostate cancer immunotherapy to identify effective combination therapies. Scientific Reports 10:1.
Crossref
Jinhui Zhang, Sangyub Kim, Li Li, Christopher J. Kemp, Cheng Jiang & Junxuan Lü. (2020) Proteomic and transcriptomic profiling of Pten gene‐knockout mouse model of prostate cancer . The Prostate 80:7, pages 588-605.
Crossref
Chao Wang, Yaping Feng, Chengyue Zhang, David Cheng, Renyi Wu, Yuqing Yang, Davit Sargsyan, Dibyendu Kumar & Ah‐Ng Kong. (2019) PTEN deletion drives aberrations of DNA methylome and transcriptome in different stages of prostate cancer. The FASEB Journal 34:1, pages 1304-1318.
Crossref
Ryuji Yamaguchi & Guy Perkins. 2020. Tumor Microenvironment. Tumor Microenvironment 19 29 .
Mohammad-Javad Sanaei, Loghman Salimzadeh & Nader Bagheri. (2020) Crosstalk between myeloid-derived suppressor cells and the immune system in prostate cancer. Journal of Leukocyte Biology 107:1, pages 43-56.
Crossref
Li Yang, Aitian Li, Qingyang Lei & Yi Zhang. (2019) Tumor-intrinsic signaling pathways: key roles in the regulation of the immunosuppressive tumor microenvironment. Journal of Hematology & Oncology 12:1.
Crossref
Sabeeh‑ur‑Rehman Butt, Muhammad S Khan, Carmen Murias, Maria Reyes Gonzalez-Exposito, Hendrik-Tobias Arkenau & Anna Patrikidou. (2019) Immunotherapy Landscape in Prostate Cancer: Successes, Failures and Promises. annals of urologic oncology, pages 1-18.
Crossref
Irina Lerman, Xiaoting Ma, Christina Seger, Aerken Maolake, Maria de la Luz Garcia-Hernandez, Javier Rangel-Moreno, Jessica Ackerman, Kent L. Nastiuk, Martha Susiarjo & Stephen R. Hammes. (2019) Epigenetic Suppression of SERPINB1 Promotes Inflammation-Mediated Prostate Cancer Progression. Molecular Cancer Research 17:4, pages 845-859.
Crossref
Yongkang Zou, Zhi Qi, Weilong Guo, Liuzhen Zhang, Marcus Ruscetti, Tanu Shenoy, Ningshu Liu & Hong Wu. (2018) Cotargeting the Cell-Intrinsic and Microenvironment Pathways of Prostate Cancer by PI3Kα/β/δ Inhibitor BAY1082439. Molecular Cancer Therapeutics 17:10, pages 2091-2099.
Crossref
Takuji Hayashi, Kazutoshi Fujita, Satoshi Nojima, Yujiro Hayashi, Kosuke Nakano, Yu Ishizuya, Cong Wang, Yoshiyuki Yamamoto, Toshiro Kinouchi, Kyosuke Matsuzaki, Kentaro Jingushi, Taigo Kato, Atsunari Kawashima, Akira Nagahara, Takeshi Ujike, Motohide Uemura, Maria Del Carmen Rodriguez Pena, Jennifer B. Gordetsky, Eiichi Morii, Kazutake Tsujikawa, George J. Netto & Norio Nonomura. (2018) High-Fat Diet-Induced Inflammation Accelerates Prostate Cancer Growth via IL6 Signaling. Clinical Cancer Research 24:17, pages 4309-4318.
Crossref
Guocan Wang, Di Zhao, Denise J. Spring & Ronald A. DePinho. (2018) Genetics and biology of prostate cancer. Genes & Development 32:17-18, pages 1105-1140.
Crossref
Jens Staal & Rudi Beyaert. (2018) Inflammation and NF-κB Signaling in Prostate Cancer: Mechanisms and Clinical Implications. Cells 7:9, pages 122.
Crossref
Tsukasa Nakamura & Hidetaka Ushigome. (2018) Myeloid-Derived Suppressor Cells as a Regulator of Immunity in Organ Transplantation. International Journal of Molecular Sciences 19:8, pages 2357.
Crossref
Hao G. NguyenCrystal S. Conn, Yae Kye, Lingru Xue, Craig M. Forester, Janet E. Cowan, Andrew C. Hsieh, John T. Cunningham, Charles Truillet, Feven Tameire, Michael J. Evans, Christopher P. Evans, Joy C. YangByron Hann, Constantinos Koumenis, Peter Walter, Peter R. CarrollDavide Ruggero. (2018) Development of a stress response therapy targeting aggressive prostate cancer. Science Translational Medicine 10:439.
Crossref
Marco Bezzi, Nina Seitzer, Tomoki Ishikawa, Markus Reschke, Ming Chen, Guocan Wang, Caitlin Mitchell, Christopher Ng, Jesse Katon, Andrea Lunardi, Sabina Signoretti, John G Clohessy, Jiangwen Zhang & Pier Paolo Pandolfi. (2018) Diverse genetic-driven immune landscapes dictate tumor progression through distinct mechanisms. Nature Medicine 24:2, pages 165-175.
Crossref
D. Alwyn Dart, Pinar Uysal-Onganer & W. G. Jiang. (2017) Prostate-specific PTen deletion in mice activates inflammatory microRNA expression pathways in the epithelium early in hyperplasia development. Oncogenesis 6:12.
Crossref
Xin Lu, Eun-Jung Jin, Xi Cheng, Shan Feng, Xiaoying Shang, Pingna Deng, Shan Jiang, Qing Chang, Sharif Rahmy, Seema Chaudhary, Xuemin Lu, Ren Zhao, Y. Alan Wang & Ronald A. DePinho. (2018) Opposing roles of TGFβ and BMP signaling in prostate cancer development. Genes & Development 31:23-24, pages 2337-2342.
Crossref
Chin-Hsien Tsai, Sheue-Fen Tzeng, Shih-Chuan Hsieh, Yu-Chih Yang, Yi-Wen Hsiao, Mong-Hsun Tsai & Pei-Wen Hsiao. (2017) A standardized herbal extract mitigates tumor inflammation and augments chemotherapy effect of docetaxel in prostate cancer. Scientific Reports 7:1.
Crossref
Irina Lerman, Maria de la Luz Garcia-Hernandez, Javier Rangel-Moreno, Luis Chiriboga, Chunliu Pan, Kent L. Nastiuk, John J. Krolewski, Aritro Sen & Stephen R. Hammes. (2017) Infiltrating Myeloid Cells Exert Protumorigenic Actions via Neutrophil Elastase. Molecular Cancer Research 15:9, pages 1138-1152.
Crossref
Geoffrey Bryant, Lin Wang & David J. Mulholland. (2017) Overcoming Oncogenic Mediated Tumor Immunity in Prostate Cancer. International Journal of Molecular Sciences 18:7, pages 1542.
Crossref
Zoila Lopez-Bujanda & Charles G Drake. (2017) Myeloid-derived cells in prostate cancer progression: phenotype and prospective therapies. Journal of Leukocyte Biology 102:2, pages 393-406.
Crossref
Haejung Won, Dayson Moreira, Chan Gao, Priyanka Duttagupta, Xingli Zhao, Edwin Manuel, Don Diamond, Yate-Ching Yuan, Zheng Liu, Jeremy Jones, Massimo D'Apuzzo, Sumanta Pal & Marcin Kortylewski. (2017) TLR9 expression and secretion of LIF by prostate cancer cells stimulates accumulation and activity of polymorphonuclear MDSCs. Journal of Leukocyte Biology 102:2, pages 423-436.
Crossref
Jared J. Barrott, Lisa A. Kafchinski, Huifeng Jin, Jared W. Potter, Sarmishta D. Kannan, Robert Kennedy, Tim Mosbruger, Wei-Lien Wang, Jen-Wei Tsai, Dejka M. Araujo, Ting Liu, Mario R. Capecchi, Alexander J. Lazar & Kevin B. Jones. (2016) Modeling synovial sarcoma metastasis in the mouse: PI3′-lipid signaling and inflammation. Journal of Experimental Medicine 213:13, pages 2989-3005.
Crossref
Amy W Ku, Jason B Muhitch, Colin A Powers, Michael Diehl, Minhyung Kim, Daniel T Fisher, Anand P Sharda, Virginia K Clements, Kieran O'Loughlin, Hans Minderman, Michelle N Messmer, Jing Ma, Joseph J Skitzki, Douglas A Steeber, Bruce Walcheck, Suzanne Ostrand-Rosenberg, Scott I Abrams & Sharon S Evans. (2016) Tumor-induced MDSC act via remote control to inhibit L-selectin-dependent adaptive immunity in lymph nodes. eLife 5.
Crossref
Xian Liu, Tristan R. Grogan, Haley Hieronymus, Takao Hashimoto, Jack Mottahedeh, Donghui Cheng, Lijun Zhang, Kevin Huang, Tanya Stoyanova, Jung Wook Park, Ruzanna O. Shkhyan, Behdokht Nowroozizadeh, Matthew B. Rettig, Charles L. Sawyers, David Elashoff, Steve Horvath, Jiaoti Huang, Owen N. Witte & Andrew S. Goldstein. (2016) Low CD38 Identifies Progenitor-like Inflammation-Associated Luminal Cells that Can Initiate Human Prostate Cancer and Predict Poor Outcome. Cell Reports 17:10, pages 2596-2606.
Crossref
Dong Lin, Xinya Wang, Stephen Yiu Chuen Choi, Xinpei Ci, Xin Dong & Yuzhuo Wang. (2016) Immune phenotypes of prostate cancer cells: Evidence of epithelial immune cell-like transition?. Asian Journal of Urology 3:4, pages 195-202.
Crossref
Huzefa Vahora, Munawwar Ali Khan, Usama Alalami & Arif Hussain. (2016) The Potential Role of Nitric Oxide in Halting Cancer Progression Through Chemoprevention. Journal of Cancer Prevention 21:1, pages 1-12.
Crossref
Hira Lal Goel, Bryan Pursell, Leonard D. Shultz, Dale L. Greiner, Rolf A. Brekken, Craig W. Vander Kooi & Arthur M. Mercurio. (2016) P-Rex1 Promotes Resistance to VEGF/VEGFR-Targeted Therapy in Prostate Cancer. Cell Reports 14:9, pages 2193-2208.
Crossref
Guocan Wang, Xin Lu, Prasenjit Dey, Pingna Deng, Chia Chin Wu, Shan Jiang, Zhuangna Fang, Kun Zhao, Ramakrishna Konaparthi, Sujun Hua, Jianhua Zhang, Elsa M. Li-Ning-Tapia, Avnish Kapoor, Chang-Jiun Wu, Neelay Bhaskar Patel, Zhenglin Guo, Vandhana Ramamoorthy, Trang N. Tieu, Tim Heffernan, Di Zhao, Xiaoying Shang, Sunada Khadka, Pingping Hou, Baoli Hu, Eun-Jung Jin, Wantong Yao, Xiaolu Pan, Zhihu Ding, Yanxia Shi, Liren Li, Qing Chang, Patricia Troncoso, Christopher J. Logothetis, Mark J. McArthur, Lynda Chin, Y. Alan Wang & Ronald A. DePinho. (2016) Targeting YAP-Dependent MDSC Infiltration Impairs Tumor Progression. Cancer Discovery 6:1, pages 80-95.
Crossref
T. Nakamura, T. Nakao, N. Yoshimura & E. Ashihara. (2015) Rapamycin Prolongs Cardiac Allograft Survival in a Mouse Model by Inducing Myeloid-Derived Suppressor Cells. American Journal of Transplantation 15:9, pages 2364-2377.
Crossref
Marcus Ruscetti, Bill Quach, Eman L. Dadashian, David J. Mulholland & Hong Wu. (2015) Tracking and Functional Characterization of Epithelial–Mesenchymal Transition and Mesenchymal Tumor Cells during Prostate Cancer Metastasis. Cancer Research 75:13, pages 2749-2759.
Crossref
Johanna A. JoyceDouglas T. Fearon. (2015) T cell exclusion, immune privilege, and the tumor microenvironment. Science 348:6230, pages 74-80.
Crossref
Charles E Massie, Inmaculada Spiteri, Helen Ross-Adams, Hayley Luxton, Jonathan Kay, Hayley C Whitaker, Mark J Dunning, Alastair D Lamb, Antonio Ramos-Montoya, Daniel S Brewer, Colin S Cooper, Rosalind Eeles, _ _Anne Y Warren, Simon Tavaré, David E Neal & Andy G Lynch. (2015) HES5 silencing is an early and recurrent change in prostate tumourigenesis. Endocrine-Related Cancer 22:2, pages 131-144.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.